Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

about

Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

Item

http://www.wikidata.org/entity/Q43042815

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

@en

Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

@nl

type

Item

label

Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

@en

Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

@nl

prefLabel

Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

@en

Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

@nl

P1476

Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.

@en

P2093

Kristin Schmerbach

http://www.w3.org/2001/XMLSchema#string

Thomas Unger

http://www.w3.org/2001/XMLSchema#string

P2860

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.

Change in symptoms of hypertensive patients after referral to hospital clinic.

The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes.

Self rated health as a predictor of coronary heart disease in Copenhagen, Denmark.

Angiotensin II receptor antagonists.

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.

P304

435-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737167.7.5.435

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20528389

http://www.w3.org/2001/XMLSchema#string